Get the Stockscreener App
4.895
7.21%
-0.375
Alector Inc stock is traded at $4.895, with a volume of 388.31K.
It is down -7.21% in the last 24 hours and up +5.84% over the past month.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.
See More
Previous Close:
$5.27
Open:
$5.17
24h Volume:
388.31K
Relative Volume:
0.81
Market Cap:
$480.77M
Revenue:
$97.06M
Net Income/Loss:
$-130.39M
P/E Ratio:
-2.8459
EPS:
-1.72
Net Cash Flow:
$-186.54M
1W Performance:
-3.55%
1M Performance:
+5.84%
6M Performance:
-9.28%
1Y Performance:
-16.84%
1-Day Range:
$4.82
$5.19
1-Week Range:
$4.82
$5.42
52-Week Range:
$3.66
$8.90
Alector Inc Stock (ALEC) Company Profile
Name
Alector Inc
Sector
Industry
Phone
415-231-5660
Address
131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO
Alector Inc Stock (ALEC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-06-23 | Downgrade | BofA Securities | Buy → Neutral |
| Sep-09-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jul-07-22 | Initiated | Mizuho | Buy |
| Apr-13-22 | Initiated | Goldman | Sell |
| Mar-08-22 | Downgrade | Stifel | Buy → Hold |
| Sep-27-21 | Initiated | William Blair | Outperform |
| Jan-15-21 | Resumed | BofA Securities | Buy |
| Jun-24-20 | Initiated | H.C. Wainwright | Buy |
| Apr-28-20 | Initiated | Goldman | Buy |
| Mar-06-20 | Initiated | Citigroup | Buy |
| Feb-27-20 | Initiated | Barclays | Overweight |
| Feb-19-20 | Initiated | Stifel | Buy |
| Nov-21-19 | Initiated | BTIG Research | Buy |
| Mar-04-19 | Initiated | Barclays | Overweight |
| Mar-04-19 | Initiated | BofA/Merrill | Buy |
| Mar-04-19 | Initiated | Morgan Stanley | Overweight |
| Mar-04-19 | Initiated | SVB Leerink | Outperform |
View All
Alector Inc Stock (ALEC) Latest News
Alector (NASDAQ:ALEC) Stock Price Up 7%Still a Buy? - MarketBeat
Precision BioSciences (DTIL) Surges 6.1%: Is This an Indication of Further Gains? - Yahoo Finance
Is Alector (NASDAQ:ALEC) In A Good Position To Deliver On Growth Plans? - Yahoo Finance
Alector, Inc. (NASDAQ:ALEC) Short Interest Update - MarketBeat
SG Americas Securities LLC Sells 33,430 Shares of Alector, Inc. (NASDAQ:ALEC) - Defense World
Alector, Inc.'s (NASDAQ:ALEC) Business And Shares Still Trailing The Industry - Simply Wall St
Alector, Inc. (NASDAQ:ALEC) Short Interest Up 19.9% in September - MarketBeat
Cubist Systematic Strategies LLC Purchases 38,947 Shares of Alector, Inc. (NASDAQ:ALEC) - Defense World
Marshall Wace LLP Lowers Position in Alector, Inc. (NASDAQ:ALEC) - MarketBeat
Was anything negative for Alector Inc (ALEC) stock last session? - US Post News
Dimensional Fund Advisors LP Has $3.07 Million Stock Position in Alector, Inc. (NASDAQ:ALEC) - MarketBeat
Alector Inc [ALEC] Chief Financial Officer makes an insider sale of 7,297 shares worth 35,620. - Knox Daily
The Future of Alector Inc: Analyzing ALEC - The InvestChronicle
Alector (ALEC) Stock Surges Over 5% Amid Positive Institutional Ratings - GuruFocus.com
ProShare Advisors LLC Sells 4,070 Shares of Alector, Inc. (NASDAQ:ALEC) - Defense World
Insider’s View: Deciphering Alector Inc (ALEC)’s Financial Health Through Ratios - The Dwinnex
Frontotemporal Dementia Pipeline 2024: Clinical Trials - openPR
Frontotemporal Dementia Pipeline 2024: Clinical Trials Assessment, FDA Approvals, Therapies, and Key Companies Involved by DelveInsight | Alector, Oncolys BioPharma, Denali Therapeutics, Passage Bio - Barchart
Recent Insider Activity Suggests Potential Gains for Alector Inc (ALEC) - Knox Daily
Cubist Systematic Strategies LLC Has $419,000 Stock Holdings in Alector, Inc. (NASDAQ:ALEC) - Defense World
Alector, Inc. (NASDAQ:ALEC) Shares Sold by American Century Companies Inc. - Defense World
Alector Inc (ALEC) Stock: A Year of Declines and Increases - The InvestChronicle
Check out these key findings about Alector Inc (ALEC) - SETE News
View On Upcoming Q4 Biotech Catalysts: Part 1 (ALEC, ARVN, AMLX) (NASDAQ:ALEC) - Seeking Alpha
Examining Alector Inc (ALEC) stock is warranted - US Post News
Keeping an Eye on Alector Inc (ALEC) After Insider Trading Activity - Knox Daily
Renaissance Technologies LLC Has $2.97 Million Stock Holdings in Alector, Inc. (NASDAQ:ALEC) - Defense World
Early Data In Hand, Vesper Bio Takes On GSK And Alector - Scrip
Alector, Inc. (NASDAQ:ALEC) Shares Sold by Profund Advisors LLC - Defense World
Alector, Inc. (NASDAQ:ALEC) Stock Holdings Increased by Caxton Associates LP - Defense World
Alector Inc (ALEC)’s highs and lows: A closer look at its stock price fluctuations - US Post News
(ALEC) On The My Stocks Page - Stock Traders Daily
We Think Alector (NASDAQ:ALEC) Needs To Drive Business Growth Carefully - Simply Wall St
Alector, Inc. (NASDAQ:ALEC) Shares Acquired by Federated Hermes Inc. - Defense World
Market Highlights: Alector Inc (ALEC) Ends on a Low Note at 5.45 - The Dwinnex
Alector (NASDAQ:ALEC) Shares Down 5.6% - MarketBeat
Alector, Inc. (NASDAQ:ALEC) Shares Bought by Massachusetts Financial Services Co. MA - Defense World
Victory Capital Management Inc. Purchases 27,094 Shares of Alector, Inc. (NASDAQ:ALEC) - Defense World
Alector (NASDAQ:ALEC) Stock Price Up 9% - Defense World
ALEC Shares Experience Surge in Value - Knox Daily
ALEC’s 52-Week Rollercoaster: From $3.66 to $8.90 – What’s Next for Investors? - The InvestChronicle
Bank of New York Mellon Corp Grows Stock Position in Alector, Inc. (NASDAQ:ALEC) - Defense World
Alector Presents Baseline Characteristics for Pivotal INFRONT-3 Phase 3 Clinical Trial at the 14th International Conference on Frontotemporal Dementias (ISFTD 2024) - GlobeNewswire
Alector (NASDAQ:ALEC) investors are sitting on a loss of 77% if they invested three years ago - Yahoo Finance
Alector, Inc. (NASDAQ:ALEC) Short Interest Down 5.7% in August - Defense World
In the Green: Alector Inc (ALEC) Closes at 5.64, Up/Down -0.70 from Previous Day - The Dwinnex
Is Alector Inc (ALEC) worth investing in despite its undervalued state? - US Post News
Alector (NASDAQ:ALEC) Receives Overweight Rating from Cantor Fitzgerald - Defense World
Short Interest in Alector, Inc. (NASDAQ:ALEC) Decreases By 5.7% - MarketBeat
Alector Inc [ALEC] Stock sold by Insider GRASSO MARC for $35620.0 - Knox Daily
Alector (NASDAQ:ALEC) Rating Reiterated by Cantor Fitzgerald - MarketBeat
Alector Inc Stock (ALEC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Alector Inc Stock (ALEC) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Rosenthal Arnon | Chief Executive Officer |
Sep 03 '24 |
Sale |
4.88 |
26,499 |
129,387 |
1,948,746 |
| Kenkare-Mitra Sara | President and Head of R&D |
Sep 03 '24 |
Sale |
4.88 |
13,926 |
67,981 |
291,715 |
| Romano Gary | Chief Medical Officer |
Sep 03 '24 |
Sale |
4.88 |
8,478 |
41,385 |
179,795 |
1.75%
0.20%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):